BBrussels Read More Brussels improves Spain’s forecasts but warns of high inflation2026-11-17 Spain is consolidating itself as the economic locomotive of the eurozone. The European Commission has improved the State’s…
AAmsterdam Read More Tickets for all Oasis ’27 live shows sold out, band confirms2026-09-28 The Burnage brothers will stop off in Glasgow, Manchester, Munich, Barcelona, Amsterdam, Paris, Rome, Boston, Las Vegas, Ireland…
AAmsterdam Read More Madonna brings out Kylie Minogue for duet at WorldPride Amsterdam – Music News2026-08-03 Madonna has surprised fans by bringing out Kylie Minogue for a special performance during WorldPride Amsterdam 2026. As…
NNovo Nordisk Read More Novo Nordisk receives European Commission approval of Wegovy® pill as first oral GLP-1 for weight management in the EU; single, ready-to-use pen for higher dose 7.2 mg also approved2026-07-30 Novo Nordisk A/S First GLP-1 pill approved in the European Union for the treatment of obesity and overweight…
NNovo Nordisk Read More Novo Nordisk receives European Commission approval of Wegovy® pill as first oral GLP-1 for weight management in the EU; single, ready-to-use pen for higher dose 7.2 mg also approved2026-07-15 Novo Nordisk A/S First GLP-1 pill approved in the European Union for the treatment of obesity and overweight…
NNovo Nordisk Read More Novo Nordisk: Wegovy® pill (semaglutide tablets) becomes first daily GLP-1 weight-loss pill approved in the UK2026-06-24 Novo Nordisk A/S Approval is based on results from the OASIS 4 trial, which investigated semaglutide tablets 25…
NNovo Nordisk Read More Novo Nordisk: Wegovy® pill (semaglutide tablets) becomes first daily GLP-1 weight-loss pill approved in the UK2026-06-11 Novo Nordisk A/S Approval is based on results from the OASIS 4 trial, which investigated semaglutide tablets 25…
NNovo Nordisk Read More Novo Nordisk A/S: Wegovy® pill (oral semaglutide) recommended by CHMP for approval in the EU as the first oral GLP-1 representing the most efficacious oral obesity treatment in its class2026-05-22 Novo Nordisk A/S With a mean weight loss of 16.6%1, Wegovy® pill demonstrates best-in-class weight-loss efficacy and is…
NNovo Nordisk Read More Novo Nordisk A/S: Wegovy® pill (oral semaglutide) recommended by CHMP for approval in the EU as the first oral GLP-1 representing the most efficacious oral obesity treatment in its class2026-05-22 Novo Nordisk A/S With a mean weight loss of 16.6%1, Wegovy® pill demonstrates best-in-class weight-loss efficacy and is…
NNovo Nordisk Read More Wegovy® pill delivered 21.6% weight loss in early responders and doubled mobility improvement, according to new Novo Nordisk data at ECO20262026-05-15 Novo Nordisk A/S Almost a third of adults taking Wegovy® pill (oral semaglutide 25 mg) were early responders…
NNovo Nordisk Read More Wegovy® pill delivered 21.6% weight loss in early responders and doubled mobility improvement, according to new Novo Nordisk data at ECO20262026-05-14 Novo Nordisk A/S Almost a third of adults taking Wegovy® pill (oral semaglutide 25 mg) were early responders…
NNovo Nordisk Read More Wegovy® pill delivered 21.6% weight loss in early responders and doubled mobility improvement, according to new Novo Nordisk data at ECO20262026-05-13 Novo Nordisk A/S Almost a third of adults taking Wegovy® pill (oral semaglutide 25 mg) were early responders…